Loading candles…
Camlin Fine Sciences is a vertically integrated global manufacturer specializing in specialty chemicals. The company focuses on shelf-life extension solutions and performance chemicals, producing antioxidants such as TBHQ (Tertiary Butylhydroquinone) and BHA (Butylated Hydroxyanisole). Its integrated production chain covers basic diphenols through to high-value customized blends tailored for various industries including specialty chemicals, food, pet food, animal nutrition, and petrochemicals. Camlin Fine Sciences serves a global market, though details on its headquarters, incorporation, founders, key management, subsidiaries, or stock listings are not specified.
This page is a live market overview for CAMLIN FINE SCIENCES LTD (CAMLINFINE) on the NSE. As a listed security, CAMLIN FINE SCIENCES LTD is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for CAMLINFINE before placing trades on tick2trade.
As of the latest feed, CAMLINFINE last traded at ₹126.58 on NSE, down ₹1.25 (0.98%) from the previous close of ₹127.83. Today's session range is ₹126.15 – ₹129.32, against a 52-week band of ₹96.21 – ₹275. Traded volume today stands at 3.02L shares.
The overview consolidates an interactive price chart with multiple time ranges, upcoming corporate events for CAMLINFINE in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether CAMLINFINE is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for CAMLIN FINE SCIENCES LTD before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in CAMLINFINE. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated CAMLINFINE option chain page linked from this overview.
| To consider and approve the proposal for issuance of equity shares of the Company by way of preferential allotment on a private placement basis . |
| 29 Sep 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended Jun 30, 2025 | 8 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 | 23 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.